Jomrich, Gerd
Yan, Winny
Kollmann, Dagmar
Kristo, Ivan
Winkler, Daniel
Puhr, Hannah
lhan-Mutlu, Aysegül
Hollenstein, Marlene
Asari, Reza
Schoppmann, Sebastian F.
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 17 July 2024
Accepted: 25 September 2024
First Online: 14 October 2024
Declarations
:
: The authors declare no competing interests.
: AIM declares following general COIs which are not directly related to the content of the manuscript: Participation in advisory boards organized by MSD, Servier, Daiichi Sankyo, BMS and Astellas, lecture honoraria from Eli Lilly, Servier, BMS, MSD, Astellas, Astra Zeneca and Daiichi Sankyo, consulting for Astellas, MSD, Amgen, Astra Zeneca and BeiGene, travel support from BMS, Roche, Eli Lilly, Daiichi Sankyo and BeiGene.
: The other authors declare that they have no conflicts of interest.
: According to its retrospective nature and in line with the ethics committees approval, written patient consent was not applicable to this study. This is in line with local ethical standards and was approved based on the ethical principles of the World Medical Association Declaration of Helsinki by the Ethics Committee of the Medical University of Vienna with the ethics vote 1132/2023. All procedures were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1964 and later versions.